BSE filing, NSE: INDIAGLYCO. Summary written from the filing by ALFA Finder's alert engine.
India Glycols Ltd: key numbers
- Share price
- ₹329.00
- Market cap
- ₹2,205 Cr
- Revenue (annual)
- ₹4,211 Cr
- Net profit (annual)
- ₹292.8 Cr
- P/E (TTM)
- 7.0×Sector 34.5×
- Promoter holding
- 59.63%+0.00% QoQ
- FII holding
- 2.77%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from India Glycols Ltd
All →India Glycols Other Announcement
The company filed its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31.
India Glycols Legal & Regulatory
India Glycols received a GST penalty order of ₹0.06 Crore from the Uttarakhand State Tax Officer, which the company intends to appeal.
- Value
- ₹0.06 Cr
- From
- State Tax Officer, SGST Department, Uttarakhand
India Glycols Price Movement Clarification
India Glycols Limited clarified that it has no undisclosed material information regarding recent share price movements. The company attributes the price fluctuation to market-driven factors.
India Glycols Other Announcement
India Glycols Ltd has submitted the quarterly certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018. The document was received from its Registrar, MCS Share Transfer Agent.
India Glycols Board Meeting Outcome
India Glycols Limited announced that its subsidiary, IGL Spirits Limited, approved share allotment under a Scheme of Arrangement and appointed new key managerial personnel.
India Glycols Management Change
India Glycols Ltd announced that four senior management personnel ceased their roles following the effective date of a previously disclosed Scheme of Arrangement.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.